Feeling sick on Mounjaro 5mg — what's happening and what to do

You injected 5mg on Sunday and by Tuesday you feel queasy every time you look at food

That's probably the most common account our prescribers hear. The jump from 2.5mg to 5mg is the first real therapeutic step in the tirzepatide schedule, and if you want to understand what the 2.5mg starter pen was doing before this point, it was about tolerance, not treatment. At 5mg, the drug's effect on gastric emptying becomes more pronounced: food moves through your stomach more slowly, appetite-signalling hormones shift, and your gut is effectively operating in a mode it has never experienced before. Nausea is a predictable consequence of that, not a sign that something has gone wrong.

The NHS tirzepatide patient guide lists nausea, vomiting, diarrhoea, constipation and indigestion as the most common side effects, and notes they're most likely to occur after starting treatment or after a dose increase. Both are true at the 5mg stage. For most people, symptoms are at their worst in the first week or two, then settle as the body recalibrates. That's the pattern, though it doesn't make Tuesday morning any easier.

If you're wondering how your experience compares to what others go through at this stage, the detailed guide on nausea at 5mg covers the picture in more depth, including how different people's timelines vary.

Practical things that actually make a difference at 5mg

Meal size matters more at this dose than it did at 2.5mg. Because gastric emptying is slower, a portion that would have been comfortable a month ago can now sit heavily and trigger nausea. Smaller plates, eaten slowly, tend to help more than any other single change. Fatty or very rich food amplifies the problem, the fat content of a meal is one of the signals that slows gastric emptying further, compounding the drug's own effect.

Timing your injection thoughtfully can also reduce the impact. Some people find that injecting in the evening means the sharpest first-day response happens overnight rather than during the working day. There's no medically correct time (it's a personal preference) but if you've been injecting Monday mornings and finding the week a write-off, shifting to a Friday evening might be worth discussing with your prescriber. Particularly useful if you're managing school runs or a full diary.

Hydration is easy to overlook when food feels unappealing. Sipping water steadily through the day, rather than drinking large amounts at once, tends to sit better. If vomiting has been significant, keeping fluids down becomes the priority. The 5mg dose overview covers how to approach this step of treatment more broadly.

Protein intake is worth protecting even when appetite is low. GLP-1 and GIP-based medicines reduce hunger indiscriminately, the body doesn't distinguish between calories from muscle and calories from fat. Preserving lean mass during rapid weight reduction requires some deliberate attention to what you eat, even in smaller amounts.

When nausea at 5mg is a signal to contact your prescriber

Most sickness at this dose is uncomfortable rather than dangerous. But there are symptoms that should prompt you to seek medical attention rather than wait it out. Severe, persistent abdominal pain (especially pain that radiates through to your back) needs same-day assessment. In January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines; that upper-abdominal pain reaching the back, with or without vomiting, is the key warning sign.

Vomiting that stops you keeping fluids down for more than 24 hours is also a reason to get in touch. Dehydration compounds quickly when you're already eating less, and the kidneys are particularly sensitive during periods of reduced fluid intake on these medicines. Severe dehydration carries its own risks.

If symptoms show no sign of improving after two to three weeks at 5mg, your prescriber may consider whether staying at 5mg longer before any further increase is the right call, or whether any dose adjustment would help. That's a clinical conversation, not something to resolve with an internet search. You can read more about the 5mg pen generally, and our clinical team's approach to titration is outlined on the clinical team page.

For anyone still on the first pen and finding the initial adjustment unexpectedly difficult, the guide to your first Mounjaro dose may put what's normal into context. And if sickness follows you into the next dose increase, the 7.5mg nausea guide is worth reading ahead of time.

Getting the right clinical oversight makes the 5mg step easier

Sickness that's managed well at 5mg sets the foundation for tolerating higher doses if that's where your treatment goes. Managed badly (through skipping doses, eating nothing, or staying silent about persistent symptoms) it can derail a course of treatment that was working. Clinical support during this stage isn't optional. It's the part that makes the difference.

Tirzepatide is a prescription medicine. Accessing it through a pharmacy you can verify on the GPhC register means your prescriber sees how you're progressing and can adjust your plan. At nume, every repeat order is reviewed by a GPhC-registered prescriber before anything is dispensed, not automatically re-sent. If you're navigating the 5mg step and want that level of oversight from the start, you can check your eligibility for a free consultation. The assessment is clinical, thorough, and reviewed the same day by a real prescriber.